glp-1 intracranial hypertension Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic | The Journal of Headache and Pain Glucagon-like peptide-1 medicines in neurological

As discussed in the CY 2026 OPPS/ASC proposed rule, we intend to provide an opportunity for the public to review the data we collect prior to use of these data in a market-based relative weight methodology

may pose choking risk in those with swallowing difficulties) Glucomannan (must be taken with sufficient water to avoid choking or oesophageal/intestinal obstruction) Inulin and other prebiotics These may indirectly support incretin secretion by slowing carbohydrate absorption, promoting beneficial gut bacteria, and stimulating L-cells in the intestine

This selective clearance reduces the accumulation of senescent cells, restores tissue homeostasis, and supports cell cycle regulation

Across SELECT, FLOW, and SURMOUNT outcome data, cardiovascular and kidney effects appear net positive over multi-year follow-up